Enter your e-mail address below
to reset your password.
Please activate your registration
by clicking the link in the activation email
or click submit to resend the activation email.
Please check your spam folder too...
Check your mailbox to activate your registration.
Please check your spam folder too.
The board of Hungarian veterinary-drug company Phylaxia 1912 Holding will raise the company's book equity by HUF 350 million to HUF 1.44 billion through an issue of 14 million dematerialized ordinary shares at a nominal value of HUF 25 per share, the company announced on Tuesday evening.
Phylaxia 1912 Holding said shareholders as of July 26 would be given preemptive rights to buy newly issued shares until August 11.
The issue is underwritten by Kálmán Böjthe, a Hungarian private individual domiciled in Germany.
Phylaxia 1912 Holding is a B-category issuer at the Budapest Stock Exchange.